The purpose of this evidence-based project was to provide patient education in order to increase human papillomavirus (HPV) vaccination rates in military women.
Abstract
The purpose of this evidence-based project was to provide patient education in order to increase human papillomavirus (HPV) vaccination rates in military women.
Despite the availability of a vaccine, HPV continues to be the most common sexually transmitted infection (STI) in the United States. The goal of this program was to increase patient knowledge and HPV vaccination rates by providing education and a verbal recommendation for vaccination during regularly scheduled well-woman exams (WWE).
The project resulted in a 65% increase in vaccination rates, raising the pre-program vaccination rate of 55% to a post-intervention vaccine percentage of 91%. The results demonstrate the importance of patient education and provider recommendation in vaccine acceptance. The Human Papillomavirus is extremely common. In fact, the American Cancer Society (ACS) compares genital HPV incidence to that of the common cold. They go on to state "nearly all sexually-active men and women get HPV at some point in their lives. This is true even for people who only have sex with one person in their lifetime" (ACS, 2014) . This is because most cases of HPV are asymptomatic, people are unaware they are infected, and over 90% of the time the body's immune system will clear the virus on its own within two years (ACS, 2014) . However, HPV remains the biggest risk factor for cervical cancer, and persistent infections with high-risk HPV subtypes (16 and 18) are associated with 99% of all cervical cancers (CDC, 2012).
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Background
So, how big could HPV's impact possibly be? In 2008 there were approximately 14.1 million newly diagnosed cases of HPV, resulting in a prevalence of 79.1 million cases (CDC, 2013) . Unfortunately, HPV has other associated complications beyond cervical cancer. HPV accounts for 90% of anal cancers, 12% of oral and pharyngeal cancers, and 40% of vulvar, and vaginal and/or penile cancers (CDC, 2012) . Another complication of HPV is anogenital warts caused by subtypes 6 and 11. An estimated 360,000 Americans contract genital warts each year (ACS, 2015) . These statistics are staggering and demonstrate the urgent need for intervention.
The population of interest for this specific evidence-based program was U.S. Navy active duty servicewomen ages 17-26 stationed in San Diego, California. Thus, it is important to examine HPV prevalence in this specific group of women as well.
According to Goyal, Mattocks, and Saddler (2012) , there are significantly higher rates of STIs, HPV, and cervical dysplasia among young servicewomen than in civilian women.
They believe this is because active duty servicewomen "tend to be young and unmarried and belong to racial and ethnic minority groups" associated with increased risk (Goyal et al., , p. 1155 . Goyal et al. (2012) went on to state:
Although data are limited, the prevalence of HPV infection may also be higher among women in the military compared to those in the general population. In studies among active duty servicewomen seeking care at an Army Medical Center STI screening clinic, prevalence of any HPV type ranged between 36% and 51%, 48, 49 which is far higher than in the general population of U.S. women (27%, 95% confidence interval [CI] 23%-31%), but similar to that found in U.S. women 20-24 years old (45%, (95% CI 36%-55%). (p. 1157)
In another study, Shen-Gunther, Shank, and Ta (2011) examined HPV vaccination rates among different groups of patients at Naval Medical Center San Diego (NMCSD). The study looked at vaccine initiation and completion rates in a large group of 5,088 patients and found that the least adherent group of patients was active duty service members.
Although the vaccine is a covered benefit provided by TRICARE, only 16% of active duty servicewomen completed the vaccination series compared to 43% of dependent daughters and 21% of dependent wives. These results indicate that there is a problem with the system and a definite need for improvement in HPV education and vaccination.
Intended Improvement
HPV is a rapidly spreading problem and will continue to be so without adequate patient education. Thus, educating and informing patients about HPV and the HPV vaccine is crucial. By giving patients knowledge, we can empower them to take control of their healthcare and pass on the information to others. Thus, the clinical objective for this evidence-based project was to provide patient education about HPV and ways to prevent/minimize its negative effects. The expected outcome was improved HPV vaccination rates.
Setting
The project was initiated at a southern Californian Naval Medical Facility madeup of a large multi-specialty inpatient hospital along with 10 branch clinics for military members and their families. The program took place at one of the branch clinics designated for active duty service members only. The program focused specifically on well women's exams (WWEs) performed by a designated female nurse practitioner in the clinic. The clinical site has a large number of female patients in the targeted age range (17-26 years) that was easily accessible during their regularly scheduled WWEs. The program involved providing face-to-face patient education about HPV with educational handouts and a specific provider recommendation for vaccination. The HPV vaccine was readily available, cost free and on-site after the visit.
Study Question
The project was designed to answer the following question: Does an educational HPV intervention result in an increased rate of HPV vaccination among U.S. Navy active duty females? With HPV incidence rates continually increasing, this is an area in which nurse practitioners can really make a significant impact and play a key role in intervention for individual patients, as well as the general public health.
Conceptual Model
This particular evidence-based project was implemented using the Iowa Model for guidance. The Iowa Model of EBP was selected because it places an emphasis on visualizing the healthcare system as a whole and identifies several steps to assist and guide the practitioner in the EBP process. The model is broadly applicable and a variety of health care disciplines can utilize and reproduce the program in their settings. For this particular project, the identified problem and/or trigger was low HPV vaccination rates.
Ethical Issues
Prior to implementation, project approval was obtained from the University of San Diego's (USD) Institutional Review Board (IRB) with permission to disseminate deidentified clinical findings. The project was also reviewed by the Regional Director of Nursing Research for the Navy Medicine West region and was approved as a quality improvement project.
Intervention Implementation
The intervention included face-to-face patient education, providing an educational handout, and giving a verbal recommendation for the HPV vaccine during regularly 
Evaluation Plan
The program was monitored and evaluated through chart reviews via an electronic medical record (EMR) system. Chart reviews were conducted prior to beginning the program to collect pre-program data, during the program, and upon completion. Charts were screened for the HPV vaccination code and to see if the HPV vaccine had been documented. Patient follow-up was completed via email and phone call if they had not received the vaccine during the visit. Upon completion of the program, data were compiled and a vaccination percentage was generated.
Results
The goal of this program was to increase patient knowledge and HPV vaccinations rates by 20% from baseline, which was achieved and exceeded. The preprogram vaccination rate was 55% and the post-intervention vaccination percentage increased to 91%, a 65% increase in vaccination rates. Throughout the 4-month program, 103 eligible patients were identified as needing the HPV vaccination and out of those, 94 patients were then vaccinated. Also, 100% of the patients seen during the program's entirety received HPV education and a recommendation for vaccination if eligible.
Discussion
The Human Papillomavirus is the most common sexually transmitted infection in the United States, yet public knowledge and vaccination rates remain low. Thus, this program set out to increase HPV awareness and increase vaccination rates among active duty servicewomen. The results of the program were impressive and in only 4 months, a 65% increase in vaccination rates was seen. By providing patients with HPV education and recommending vaccination, the program created a new average vaccination rate of 91% of eligible patients, up from the previous baseline of 55%.
Another current organization encouraging HPV vaccination is the U.S.
Department of Health and Human Services' (USDHHS), and Healthy People 2020
(HP2020) objectives seek to increase routine HPV vaccination coverage for adolescents.
Immunization and Infectious Disease (IID) objectives 11.4 and 11.5 outline goals to increase HPV vaccination coverage for females (IID-11.4) and males (IID-11.5) ages 13-15 to 80% (USDHHS, 2015) . These target goals are important; however they only cover a specific age range and do not cover those females and males who were not vaccinated as adolescents. There are no benchmark goals for older adolescents or young adults even though the Gardasil vaccine is approved for females and males ages 9-26. This evidencebased program in military servicewomen exceeded the HP2020 benchmark vaccination goal of 80% for ages 13-15 years and demonstrated the importance of continuing to educate about HPV and encourage vaccination among older adolescents and young adults.
The program results suggest that education about HPV will improve vaccination rates. Thus, if health care providers educate patients, parents, and society about HPV, we may see an increase in vaccination. One of the main arguments against vaccination is a parental concern that it promotes sexual activity at a younger age. A recent study done by , found that HPV vaccination was not associated with increased STI rates in a large cohort of females ages 12-18, suggesting that HPV vaccination is unlikely to cause unsafe sexual practices . Studies such as this one and evidence found from this project can be utilized by health care providers to have informed conversations with patients and parents about HPV to decrease concerns about vaccination.
In conclusion, these results demonstrate the importance of patient and provider education about HPV and the need for vaccination recommendations from health care
providers. Future evidence-based projects should replicate this program in other clinical sites to improve vaccination rates and increase awareness.
Conclusions and Implications
HPV is a rapidly spreading problem and will continue to be so without accurate patient education and vaccine recommendations from health care providers. By supplying patients with knowledge, we can empower them to take control of their own health and inspire them to pass on their learned experience to others. Health care professionals play a key role in the patient education process and research has linked patient education and vaccine recommendations to increased acceptance of HPV vaccine. Cervical cancer is a preventable disease; together we can make a difference. • 79 million Americans are currently infected with HPV, 14 million individuals will become infected annually, leading to more than 10,000 cases of cervical cancer each year (CDC, 2013) • Research demonstrates that young military servicewomen have significantly higher rates of STIs, HPV, and cervical dysplasia
• A U.S. Army medical center STI clinic found that HPV rates in service women ranged from 36-51%, which is higher than the U.S. general population (Goyal, Mattocks, & Saddler, 2012) • Program took place at a southern California Naval Branch Health Clinic providing care to a large population of active duty servicewomen in the targeted age group of (18-26) years old
EVIDENCE CONCLUSIONS/IMPLICATIONS FOR CLINICAL PRACTICE TABLES/GRAPHS
• The health care provider responsible for women's health visits in an active duty military treatment facility provided patient education during regularly scheduled annual and/or initial well woman exams.
• Patients received an educational handout and a verbal recommendation for the HPV vaccine • HPV is the biggest risk factor for cervical cancer (CDC, 2012) • Vaccines such as Gardasil are currently considered one of the safest and most effective ways to prevent cervical cancer and other HPV related complications (CDC, 2013) • Educational interventions to increase HPV awareness and vaccination help to boost vaccination rates (Kester, 2014) • HPV vaccine uptake and acceptability increased when patients were given education and a recommendation for vaccination from their health care provider (Brewer & Fazekas, 2007) • Patients were 5 times more likely to receive the HPV vaccine if a recommendation was given by their health care provider versus those who did not receive a recommendation (Ylitalo, Lee, & Mehta, 2013) .
• (CDC, 2013) • HPV is biggest risk factor for cervical cancer (CDC, 2012) • Studies have found military servicewomen having higher rates of STIs, HPV, and cervical dysplasia (Goyal, Mattocks, & Saddler, 2012) 31 
